CeloNova

About:

CeloNova BioSciences is a medical device firm that develops, manufactures and markets interventional cardiology and endovascular products.

Website: http://celonova.com

Twitter/X: CeloNova

Top Investors: WP Global Partners, FCA Venture Partners, Clayton Associates

Description:

CeloNova BioSciences, Inc., headquartered in San Antonio, Texas, is a global medical device company that develops, manufactures and markets a family of Interventional Cardiology and Endovascular products. Our products are developed and manufactured in California, U.S.A. and Germany. The Company’s regional offices are located in Germany, France, United Kingdom, Netherlands and Austria. CeloNova’s Interventional Cardiology and Endovascular products are currently available in more than fifty countries.

Total Funding Amount:

$20.8M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Antonio, Texas, United States

Founded Date:

2000-01-01

Contact Email:

info(AT)celonova.com

Founders:

Goetz Richter

Number of Employees:

51-100

Last Funding Date:

2018-11-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai